Zhang Zhuan, Pan Hai-Xue, Tang Gong-Li
State Key Laboratory of Bio-organic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China.
F1000Res. 2017 Feb 21;6:172. doi: 10.12688/f1000research.10466.1. eCollection 2017.
Bacterial aromatic polyketides, exemplified by anthracyclines, angucyclines, tetracyclines, and pentangular polyphenols, are a large family of natural products with diverse structures and biological activities and are usually biosynthesized by type II polyketide synthases (PKSs). Since the starting point of biosynthesis and combinatorial biosynthesis in 1984-1985, there has been a continuous effort to investigate the biosynthetic logic of aromatic polyketides owing to the urgent need of developing promising therapeutic candidates from these compounds. Recently, significant advances in the structural and mechanistic identification of enzymes involved in aromatic polyketide biosynthesis have been made on the basis of novel genetic, biochemical, and chemical technologies. This review highlights the progress in bacterial type II PKSs in the past three years (2013-2016). Moreover, novel compounds discovered or created by genome mining and biosynthetic engineering are also included.
以蒽环类抗生素、安古霉素、四环素和五角多酚为代表的细菌芳香族聚酮化合物是一大类结构多样、具有生物活性的天然产物,通常由II型聚酮合酶(PKSs)生物合成。自1984 - 1985年生物合成和组合生物合成起步以来,由于迫切需要从这些化合物中开发出有前景的治疗候选物,人们一直在不断努力研究芳香族聚酮化合物的生物合成逻辑。近年来,基于新的遗传学、生物化学和化学技术,在参与芳香族聚酮化合物生物合成的酶的结构和机制鉴定方面取得了重大进展。本综述重点介绍了过去三年(2013 - 2016年)细菌II型PKSs的研究进展。此外,还包括通过基因组挖掘和生物合成工程发现或创造的新化合物。